1. Leader, S, Kohlhase, K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatric Infectious Disease Journal 2002; 21: 629–632.
2. Shay, DK, et al. Bronchiolitis-associated hospitalizations among US children, 1980–1996. Journal of the American Medical Association 1999; 282: 1440–1446.
3. Sigurs, N, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. American Journal of Respiratory and Critical Care Medicine 2000; 161: 1501–1507.
4. Denny, FW, Clyde, WA Jr.. Acute lower respiratory tract infections in nonhospitalized children. Journal of Pediatrics 1986; 108: 635–646.
5. Laham, FR, et al. Differential production of inflammatory cytokines in primary infection with human metapneumonirus and with other common respiratory viruses of infancy. Journal of Infectious Diseases 2004; 189: 47–56.
6. Chew, FT, et al. Seasonal trends of viral respiratory tract infections in the tropics. Epidemiology and Infection 1998; 121: 121–128.
7. Chan, PWK, et al. Seasonal variation in respiratory syncytial virus chest infection in the tropics. Pediatric Pulmonology 2002; 34: 47–51.
8. Groothuis, JR, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. New England Journal of Medicine 1993; 329: 1524–1530.
9. The IM-pact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531–537.
10. Hall, CB, Douglas, RG Jr.. Modes of transmission of respiratory syncytial virus. Journal of Pediatrics 1981; 99: 100–103.
11. Rechsteiner, J, Winkler, KC. Inactivation of respiratory syncytial virus in aerosol. Journal of General Virology 1969; 5: 405–410.
12. Hambling, MH. Survival of the respiratory syncytial virus during storage under various conditions. British Journal of Experimental Pathology 1964; 45: 647–655.
13. Wang, TT, et al. 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology 2004; 173: 2909–2912.
14. Gombart, AF, Luong, QT, Koeffler, HP. Vitmin D compounds: activity against microbes and cancer. Anticancer Research 2006; 26: 2531–2542.
15. Liu, PT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770–1773.
16. Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nature Reviews Immunology 2003; 3: 710–720.
17. Daher, KA, Selsted, ME Lehrere RI. Direct inactivation of viruses by human granulocyte defensins. Journal of Virology 1986; 60: 1068–1074.
18. Holick, MF. Resurrection of vitamin D and rickets. Journal of Clinical Investigation 2006; 116: 2062–2072.
19. Rehman, PK. Sub-clinical rickets and recurrent infection. Journal of Tropical Pediatrics 1994; 40: 58.
20. Cannell, JJ, et al. Epidemic influenza and vitamin D. Epidemiology and Infection 2006; 134: 1129–1140.
21. Cherian, T, et al. Bronchiolitis in tropical South India. American Journal of Diseases of Children 1990; 144: 1026–1030.
22. Gilchrist, S, et al. National surveillance for respiratory syncytial virus, United States, 1985–1990. Journal of Infectious Diseases 1994; 170: 986–990.
23. Washburne, JF, Bocchini, JA Jr., Jamison, RM. Summertime respiratory syncytial virus infection: epidemiology and clinical manifestations. Southern Medical Journal 1992; 85: 579–583.
24. Halstead, DC, Jenkins, SG. Continuous non-seasonal epidemic of respiratory syncytial virus infection in the Southeast United States. Southern Medical Journal 1998; 91: 433–436.
25. Huq, F, et al. Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh. Review of Infectious Diseases 1990; 12 (Suppl. 8): S982–S987.
26. Sung, RYT, et al. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants. Epidemiology and Infection 1992; 108: 147–154.
27. Mullins, JA, et al. Substantial variablilty in community respiratory syncytial virus season timing. Pediatric Infectious Disease Journal 2003; 22: 857–862.
28. Welliver, RC. Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clinical Microbiology Reviews 1988; 1: 27–39.
29. Barone, SR. Rapid diagnosis of infection with respiratory syncytial virus. Report on Pediatric Infectious Diseases 1997; 7: 6–7.
30. Weber, MW, et al. The clinical spectrum of respiratory syncytial virus disease in The Gambia. Pediatric Infectious Disease Journal 1998; 17: 224–230.
31. Jamjoom, GA, et al. Respiratory syncytial virus infection in young children hospitalized with respiratory illness in Riyadh. Journal of Tropical Pediatrics 1993; 39: 346–349.
32. Hijazi, Z, et al. Respiratory syncytial virus infections in children in a desert country. Pediatric Infectious Disease Journal 1995; 14: 322–324.
33. Florman, AL, McLaren, LC. The effect of altitude and weather on the occurrence of outbreaks of respiratory syncytial virus infections. Journal of Infectious Diseases 1988; 158: 1401–1402.
34. Orstavik, I, Carlsen, K-HC, Halvorsen, K. Respiratory syncytial virus infections in Oslo 1972–1978. Acta Paediatrica Scandinavica 1980; 69: 717–722.